Log on / register
Feedback | Support | My details
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients.
Fehm T, Krawczyk N, Solomayer EF, Becker-Pergola G, Dürr-Störzer S, Neubauer H, Seeger H, Staebler A, Wallwiener D, Becker S
Breast Cancer Res 2008, 10:R76
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article    
Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer
Schwarzenbach H, Pantel K, Kemper B, Beeger C, Otterbach F, Kimmig R, Kasimir-Bauer S
Breast Cancer Research 2009, 11:R71 (21 September 2009)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

2.


Research article    
Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells
Fehm T, Hoffmann O, Aktas B, Becker S, Solomayer EF, Wallwiener D, Kimmig R, Kasimir-Bauer S
Breast Cancer Research 2009, 11:R59 (10 August 2009)
[Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

3.


Research article    
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S
Breast Cancer Research 2009, 11:R46 (9 July 2009)
[Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

4.


Editorial    
On the way to specifically targeting minimal residual disease?
Gebauer G
Breast Cancer Research 2008, 10:112 (7 October 2008)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.